Sleep

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide first isolated in 1977 from the cerebral venous blood of rabbits during electrically induced sleep by Schoenenberger and Monnier at the University of Basel. The peptide is named for its ability to enhance delta wave activity during slow-wave sleep (stage 3/4 NREM sleep), the deepest phase of the sleep cycle associated with physical restoration, growth hormone release, and memory consolidation. DSIP is found endogenously in the brain, pituitary gland, and peripheral organs, with levels that fluctuate in a circadian pattern. Despite its short plasma half-life of approximately 7-8 minutes, its central effects on sleep architecture persist for hours, suggesting either rapid CNS uptake, conversion to longer-acting metabolites, or triggering of downstream cascades that outlast the peptide itself. Research interest has expanded beyond sleep to include stress adaptation, pain modulation, and neuroendocrine regulation, though clinical development has been limited.